Obesity has become one of the biggest health problems in the world today. It affects millions of people and increases the risk of serious diseases such as heart disease, type 2 diabetes, and certain types of cancer.
For many people, losing weight is not easy, even with diet and exercise. This makes the search for effective treatments very important.
At the moment, there are only limited options for treating severe obesity. While lifestyle changes like eating healthier and exercising more can help, they do not always work for everyone.
Many people find it very hard to maintain long-term weight loss. Because of this, scientists have been trying to develop medicines that can safely and effectively help people lose weight.
Now, a new study from Johns Hopkins Medicine has brought some exciting news. Researchers have been studying a drug that was originally created for other health problems, including Alzheimer’s disease, schizophrenia, and sickle cell disease. Although the drug did not succeed in treating those conditions, it may have a new and unexpected use.
The drug works by targeting an enzyme in the body called PDE9. Enzymes are substances that help control different processes in the body. In this case, PDE9 affects how cells use a chemical messenger called cyclic GMP, which plays an important role in many body functions.
The study found that blocking this enzyme could lead to several health benefits. In experiments with mice, the drug helped reduce body fat and improve fatty liver disease. It also improved heart function. What makes this finding especially interesting is that the mice did not need to change their diet or exercise more to see these benefits.
This research builds on earlier work from the same team. In 2015, the scientists discovered that the PDE9 enzyme is active in the heart and can make heart disease worse, especially in people with high blood pressure. This led them to wonder whether blocking the enzyme could have wider health benefits beyond the heart.
The type of drug used in the study is called a PDE9 inhibitor. It works in a similar way to well-known drugs like Viagra, which targets a related enzyme called PDE5. Both of these enzymes influence the levels of cyclic GMP in the body, which affects how blood vessels relax and how cells function.
In their study, the researchers wanted to see if blocking PDE9 could improve several problems linked to obesity. They looked at whether it could reduce high blood pressure, lower blood sugar levels, improve cholesterol levels, and reduce fat stored in the body, especially around the waist.
The specific drug tested in the study is called PF-04447943. It was originally developed by Pfizer Inc. as a treatment for Alzheimer’s disease. Although it did not work for that purpose, it was tested in more than 100 people and was found to be safe, with no serious side effects reported.
Obesity is very common, especially in the United States. According to the Centers for Disease Control and Prevention, more than 40 percent of adults in the U.S. are obese. The numbers are even higher among older adults. This shows how urgent it is to find better treatments.
If the results seen in mice can also be achieved in humans, the impact could be very large. The researchers suggest that a person weighing around 250 pounds might be able to lose about 50 pounds by taking this type of drug, even without changing their eating habits or exercise routine.
The study was led by Dr. David Kass and was published in the Journal of Clinical Investigation. It offers a new way of thinking about obesity and how it can be treated. Instead of focusing only on diet and exercise, it suggests that the body’s internal systems also play an important role.
This idea challenges the common belief that obesity is only caused by eating too much. It shows that biological factors can also make it harder for some people to control their weight.
However, it is important to be careful. These findings are still based on animal studies. More research is needed to see if the drug works the same way in humans. Scientists also need to confirm that it is safe for long-term use.
Even so, this discovery offers new hope. If future studies are successful, this type of drug could become a powerful tool in the fight against obesity. It could make weight loss easier and more achievable for many people around the world.
If you care about weight loss, please read studies that hop extract could reduce belly fat in overweight people, and early time-restricted eating could help lose weight .
For more health information, please see recent studies that Mediterranean diet can reduce belly fat much better, and Keto diet could help control body weight and blood sugar in diabetes.
Copyright © 2026 Knowridge Science Report. All rights reserved.
